In conclusion, we showed that both MSCs and BMMNCs were effective in terms of improving LVEF and decreasing BNP compared with placebo in patients with chronic heart failure and no apparent difference was observed between the two types of cells. The gene discussed is NPPB; the disease is congestive heart failure.